2025 annual financial data
Keros Therapeutics 2025 Financial results
Direct answer
Revenue was 244.06M USD.
Operating income was 70.62M USD and net income was 87.01M USD.
Operating cash flow was 107.51M USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 244.06M USD
- Operating income
- 70.62M USD
- Net income
- 87.01M USD
- Operating cash flow
- 107.51M USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Keros Therapeutics financial years